Filing Details
- Accession Number:
- 0001593968-21-002359
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-03 20:10:42
- Reporting Period:
- 2021-11-02
- Accepted Time:
- 2021-11-03 20:10:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
738214 | Aemetis Inc | AMTX | Industrial Organic Chemicals (2860) | 261407544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236181 | P Francis Barton | 20400 Stevens Crek Blvd, Suite 700 Cupertino CA 95014 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-02 | 9,445 | $2.54 | 22,897 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-11-03 | 10,555 | $2.54 | 33,452 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-11-02 | 9,445 | $21.13 | 24,007 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-11-03 | 10,555 | $21.12 | 13,452 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock And Series B Preferred | Option (right to buy) | Disposition | 2021-11-02 | 9,445 | $0.00 | 9,445 | $2.54 |
Common Stock And Series B Preferred | Option (right to buy) | Disposition | 2021-11-03 | 10,555 | $0.00 | 10,555 | $2.54 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
41,555 | 2016-05-20 | 2026-05-21 | No | 4 | M | Direct |
31,000 | 2016-05-20 | 2026-05-21 | No | 4 | M | Direct |
Footnotes
- These shares were sold pursuant to a Rule 10b5-1 plan.
- As of the date of the filing of this Form 4, the Reporting Person beneficially owned 13,452 shares of the Issuers common stock.
- 50% vest Immediately on the grant date and rest 50% vest 1/12th over the three years.